Aldosterone regulates vascular reactivity - Short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation

被引:147
作者
Liu, SL
Schmuck, S
Chorazcyzewski, JZ
Gros, R
Feldman, RD
机构
[1] John P Robarts Res Inst, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada
[3] Univ Western Ontario, Dept Med, London, ON, Canada
关键词
arteries; endothelium; hormones; vasodilation;
D O I
10.1161/01.CIR.0000093188.53554.44
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-There is increasing evidence for rapid nongenomic effects of aldosterone. Therefore, we studied the immediate effects of aldosterone on vascular reactivity in rat aortic ring segments and on endothelial and vascular smooth muscle cellular responses. Methods and Results-In endothelium-intact ring segments, aldosterone attenuated phenylephrine-mediated constriction (maximal reduction, 25+/-4% below control phenylephrine-mediated constriction). In contrast, in endothelium-denuded vessels, aldosterone mediated a monophasic dose-dependent enhancement of vasoconstrictor response. In endothelial cells, aldosterone caused a phosphatidylinositol 3-kinase (PI3K)-dependent increase in nitric oxide synthase activity as well as PI3K-dependent activation of extracellular signal-regulated kinase 1/2 and p70 S6 kinase. Conclusions-Overall, these data support a novel effect of aldosterone on vascular endothelial and smooth muscle cell function. These rapid effects of aldosterone might be important in both the short- and long-term regulation of peripheral vascular resistance. Furthermore, in the setting of endothelial dysfunction, alterations in aldosterone's short- term vascular responses might contribute to its pathophysiological effects in cardiovascular disease.
引用
收藏
页码:2400 / 2406
页数:7
相关论文
共 38 条
  • [1] AHN NG, 1990, J BIOL CHEM, V265, P11487
  • [2] REMODELING OF THE RAT RIGHT-AND-LEFT-VENTRICLES IN EXPERIMENTAL-HYPERTENSION
    BRILLA, CG
    PICK, R
    TAN, LB
    JANICKI, JS
    WEBER, KT
    [J]. CIRCULATION RESEARCH, 1990, 67 (06) : 1355 - 1364
  • [3] Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells
    Christ, M
    Günther, A
    Heck, M
    Schmidt, BMW
    Falkenstein, E
    Wehling, M
    [J]. CIRCULATION, 1999, 99 (11) : 1485 - 1491
  • [4] PDGF-DEPENDENT AND INSULIN-DEPENDENT PP70(S6K) ACTIVATION MEDIATED BY PHOSPHATIDYLINOSITOL-3-OH KINASE
    CHUNG, JK
    GRAMMER, TC
    LEMON, KP
    KAZLAUSKAS, A
    BLENIS, J
    [J]. NATURE, 1994, 370 (6484) : 71 - 75
  • [5] CONKLIN BR, 1992, J BIOL CHEM, V267, P31
  • [6] INFLUENCE OF ARTERIAL BLOOD-PRESSURE AND ALDOSTERONE ON LEFT-VENTRICULAR HYPERTROPHY IN MODERATE ESSENTIAL-HYPERTENSION
    DUPREZ, DA
    BAUWENS, FR
    DEBUYZERE, ML
    DEBACKER, TL
    KAUFMAN, JM
    VANHOECKE, J
    VERMEULEN, A
    CLEMENT, DL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) : A17 - A20
  • [7] Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients
    Duprez, DA
    De Buyzere, NL
    Rietzschel, ER
    Taes, Y
    Clement, DL
    Morgan, D
    Cohn, JN
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 (09) : 1371 - 1376
  • [8] Falkenstein E, 2000, PHARMACOL REV, V52, P513
  • [9] Aldosterone induces acute endothelial dysfunction in vivo in humans:: evidence for an aldosterone-induced vasculopathy
    Farquharson, CAJ
    Struthers, AD
    [J]. CLINICAL SCIENCE, 2002, 103 (04) : 425 - 431
  • [10] FELDMAN RD, 1993, MOL PHARMACOL, V44, P393